GO:0010468 regulation of gene expression: Core Regulatory Layer, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0010468 regulation of gene expression describes any process that modulates the frequency, rate or extent of gene expression, the conversion of a gene's coding sequence into a mature RNA or protein product.
• Regulation occurs at multiple layers, including chromatin and histone modification, transcription, RNA processing and stability, translation, and protein turnover.
• Cis-acting long non-coding RNAs and epigenetic marks are central regulators that can activate or repress expression of target loci.
• Dysregulation of gene expression is a hallmark of cancer, leukemia, and many other human diseases, making this process a major therapeutic focus.
• Post-transcriptional control, including mRNA stability and translation efficiency, is a frequent driver of disease when perturbed.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable causal testing of regulatory genes and elements within this GO term.
Description
Regulation of gene expression (GO:0010468) is the biological process that modulates the frequency, rate or extent of gene expression, where gene expression is the conversion of a gene's coding sequence into a mature gene product such as RNA or protein. This process is fundamental because it determines which genes are active in a given cell, at what level, and under what conditions, thereby shaping cell identity, development, and responses to environmental signals. Research over recent decades has shown that regulation operates at multiple layers, from chromatin and histone modifications to transcription, RNA processing, translation, and protein stability. Because misregulation of gene expression underlies many human diseases, including cancer and leukemia, understanding the mechanisms and key regulators of GO:0010468 is essential for both basic biology and therapeutic development. This article integrates the QuickGO definition with verified literature to provide a research-grade overview of the process, its key genes, disease links, and experimental methods used to study it.
regulation of gene expression At A Glance
| GO ID | GO:0010468 |
|---|---|
| GO term | regulation of gene expression |
| Ontology | biological_process |
| Synonym | gene regulation; regulation of gene product expression; regulation of protein expression |
| Definition | Any process that modulates the frequency, rate or extent of gene expression; gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA). |
| Major function | Controls when, where, and how much a gene is expressed, integrating transcriptional, post-transcriptional, and epigenetic inputs. |
| Key layers | Chromatin/histone modification, transcription, RNA processing and stability, translation, and protein turnover. |
| Disease relevance | Dysregulation is central to cancer, leukemia, and other human diseases. |
| Research methods | CRISPR screens, RNA-seq, Ribo-seq, proteomics, and reporter assays. |
What Is GO:0010468?
According to the Gene Ontology, GO:0010468 regulation of gene expression is defined as any process that modulates the frequency, rate or extent of gene expression, where gene expression is the process in which a gene's coding sequence is converted into a mature gene product, either protein or RNA. In practice, this includes mechanisms that control transcription initiation and elongation, RNA processing and stability, translation, and the abundance or activity of the final gene product. The term is a biological process and encompasses both positive and negative regulation, often referred to as gene regulation, regulation of gene product expression, or regulation of protein expression.
Why Is regulation of gene expression Important in Cell Biology?
Regulation of gene expression is essential because it allows a single genome to produce the thousands of distinct cell types and functional states found in multicellular organisms, and it enables cells to adapt to metabolic, developmental, and environmental cues. When this regulation fails, the consequences include uncontrolled proliferation in cancer, impaired differentiation in leukemia, and altered stress responses in other diseases. Moreover, pharmacological and synthetic biology approaches that target gene expression are increasingly used to treat disease or engineer desired traits, underscoring the practical importance of understanding GO:0010468.
• Controls cell identity and differentiation by determining which genes are active in each cell type.
• Enables rapid adaptation to metabolic and environmental changes through histone acylation and other epigenetic mechanisms.
• Is a central driver of cancer when transcriptional or post-transcriptional control is lost.
• Plays a key role in leukemia through signaling and epigenetic regulation.
• Involves cis-acting long non-coding RNAs that fine-tune expression of neighboring genes.
• Post-transcriptional regulation defects contribute to a wide range of human diseases.
• Is a target for pharmacological intervention to modulate gene expression therapeutically.
• Can be engineered using synthetic biology approaches for targeted gene expression control.
• Provides a framework for CRISPR-based functional genomics of regulatory elements and factors.
• Underpins host-pathogen interactions, as shown by lysine acetylation in Salmonella.
What Happens During regulation of gene expression?
Chromatin and histone modification
In simple terms: Chemical tags on DNA-packaging proteins can open or close the book of genes.
Histone modifications such as acetylation and acylation alter chromatin structure and recruit reader proteins that either promote or repress transcription, thereby modulating the frequency and rate of gene expression. These marks are dynamic and respond to metabolic cues, linking cellular metabolism to gene regulation.
Transcription initiation and elongation
In simple terms: The cell decides when and how fast to copy a gene into RNA.
Transcription factors and coactivators bind regulatory elements to recruit RNA polymerase II and control initiation, while elongation factors and chromatin remodelers influence the rate of RNA synthesis. Cis-acting long non-coding RNAs can also modulate transcription by recruiting or scaffolding regulatory complexes at target loci.
RNA processing and stability
In simple terms: After RNA is made, it can be edited, transported, or destroyed to control how much protein is produced.
Post-transcriptional regulation includes splicing, capping, polyadenylation, export, and mRNA decay, all of which determine the amount of mature RNA available for translation. Defects in these steps are linked to human disease, highlighting their importance in gene expression control.
Translation and protein turnover
In simple terms: The cell controls how much protein is made from each RNA and how quickly that protein is removed.
Translation initiation, elongation, and termination are regulated by signaling pathways and RNA-binding proteins, while protein stability is controlled by ubiquitination and proteolysis. Together, these steps fine-tune the final gene product level, completing the regulation of gene expression.
Signaling and epigenetic integration
In simple terms: External signals can change which genes are turned on or off.
Cellular signaling pathways, including those involving epigenetic modifiers, integrate developmental and environmental cues to regulate gene expression programs in leukemia and other contexts. Pharmacological agents can also modulate these pathways to alter gene expression.
Key Genes Involved in GO:0010468 regulation of gene expression
The following genes and proteins are representative regulators and effectors within GO:0010468, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EP300 | Histone acetyltransferase that promotes transcription | Studied for its role in chromatin modification and gene activation |
| CREBBP | Transcriptional coactivator with histone acetyltransferase activity | Implicated in leukemia and epigenetic regulation |
| HDAC1 | Histone deacetylase that represses transcription | Target for pharmacological regulation of gene expression |
| HDAC2 | Histone deacetylase involved in chromatin compaction | Studied in cancer and epigenetic therapy |
| KAT2A | Histone acetyltransferase component of SAGA complex | Linked to transcriptional regulation and metabolism |
| KAT2B | Histone acetyltransferase and coactivator | Role in gene expression and disease models |
| SIRT1 | NAD+-dependent deacetylase | Connects metabolism to gene regulation |
| MYC | Transcription factor controlling proliferation genes | Frequently dysregulated in cancer |
| TP53 | Transcription factor regulating stress response genes | Central to cancer gene expression programs |
| STAT5A | Signal transducer and transcription factor | Key in leukemia gene expression |
| STAT5B | Signal transducer and transcription factor | Key in leukemia gene expression |
| NFKB1 | Transcription factor mediating immune and inflammatory gene expression | Studied in cancer and inflammation |
| XIST | Long non-coding RNA that regulates X-chromosome inactivation | Model for cis-acting lncRNA regulation |
| HOTAIR | Long non-coding RNA that modulates chromatin state | Studied in cancer gene expression |
| MALAT1 | Long non-coding RNA involved in splicing regulation | Linked to post-transcriptional control |
| EIF4E | Translation initiation factor | Target for post-transcriptional regulation studies |
| UPF1 | RNA helicase in nonsense-mediated decay | Key for mRNA stability and disease |
How Is regulation of gene expression Regulated?
Regulation of gene expression is itself regulated by multiple inputs, including metabolic signals that influence histone acylation, signaling pathways that control transcription factor activity, and pharmacological agents that can modulate epigenetic enzymes. For example, lysine acetylation in Salmonella is a regulated process that affects gene expression during infection. Additionally, synthetic biology approaches allow targeted control of gene expression using engineered regulators.
regulation of gene expression and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MYC | Cancer (multiple types) | Knockout or overexpression in cancer cell lines |
| STAT5A | Leukemia | Point mutation or knockout in hematopoietic cells |
| EP300 | Cancer and developmental disorders | Knock-in of acetyltransferase-dead mutants |
| UPF1 | Post-transcriptional disease | Knockout in human cell lines to study mRNA decay |
| HOTAIR | Cancer metastasis | Overexpression or knockout in cancer models |
Cancer
Dysregulation of gene expression is a hallmark of cancer, where altered transcription factor activity, epigenetic marks, and non-coding RNA networks drive uncontrolled proliferation and survival. Many oncogenes and tumor suppressors function by modulating gene expression programs, making this process a prime therapeutic target.
Leukemia
In leukemia, aberrant cellular signaling and epigenetic regulation converge to reprogram gene expression, contributing to leukemogenesis and therapy resistance. Key transcription factors such as STAT5 and epigenetic modifiers are frequently altered in leukemia.
Post-transcriptional regulation and human disease
Defects in post-transcriptional regulation, including mRNA decay and translation control, cause or contribute to a range of human diseases, underscoring the importance of RNA-level regulation within GO:0010468.
Infectious disease
Pathogens such as Salmonella regulate gene expression through protein lysine acetylation to adapt to host environments, illustrating the role of this process in infection.
From regulation of gene expression-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate transcription factor required for gene expression? | CRISPR knockout cell line |
| Does a specific phosphorylation site regulate activity? | CRISPR point mutation knock-in |
| How does a disease-associated mutation affect gene regulation? | Knock-in of mutant allele |
| Where and when is a regulator expressed? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression drive oncogenic gene expression? | CRISPR overexpression model |
| Which regulatory genes are essential in a pathway? | CRISPR library screening |
How to Study the regulation of gene expression Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Steady-state RNA levels | Global gene expression profiling |
| Ribo-seq | Translated mRNA fragments | Translational regulation studies |
| ChIP-seq | Protein-DNA interactions | Transcription factor and histone mark mapping |
| ATAC-seq | Chromatin accessibility | Regulatory element identification |
| Proteomics | Protein abundance and modifications | Post-translational regulation |
| Reporter assays | Transcriptional activity | Promoter and enhancer studies |
| CRISPR screens | Gene function at scale | Identifying regulators of gene expression |
| Single-cell RNA-seq | Cell-to-cell expression heterogeneity | Developmental and disease studies |
Transcriptomics (RNA-seq)
RNA sequencing measures steady-state RNA levels and can identify changes in gene expression upon perturbation of regulatory factors, providing a global view of GO:0010468.
Ribo-seq and translation profiling
Ribosome profiling captures translating mRNAs, allowing researchers to separate transcriptional from translational regulation within gene expression control.
Proteomics and post-translational modification analysis
Mass spectrometry-based proteomics can quantify protein abundance and modifications such as acetylation, linking epigenetic marks to gene expression outcomes.
Imaging and reporter assays
Fluorescent reporters and live-cell imaging enable real-time monitoring of gene expression dynamics in single cells, complementing population-level methods.
How CRISPR Can Be Used to Study GO:0010468 regulation of gene expression
Knockout
CRISPR knockout of a candidate regulatory gene can determine whether it is required for expression of target genes, providing causal evidence within GO:0010468.
Point Mutation
Introducing precise point mutations in regulatory proteins or cis-elements allows testing of specific residues or motifs in gene expression control.
Knock-in
Knock-in of reporter tags or disease alleles enables tracking of expression dynamics and modeling of regulatory mutations.
Overexpression
CRISPR activation or cDNA overexpression can test sufficiency of a regulator to drive gene expression changes, complementing loss-of-function studies.
How EDITGENE Supports regulation of gene expression Research
Researchers studying regulation of gene expression-related genes often need to determine whether a candidate gene is causally involved in a specific expression program, and CRISPR-based models provide a direct way to test this. EDITGENE offers a suite of services to generate such models efficiently.
Contact EDITGENE today to design your custom CRISPR model for regulation of gene expression research.
Frequently Asked Questions About regulation of gene expression
What is regulation of gene expression (GO:0010468)?
It is any process that modulates the frequency, rate or extent of gene expression, the conversion of a gene's coding sequence into a mature RNA or protein product.
What genes are involved in regulation of gene expression?
Key genes include transcription factors such as MYC and TP53, epigenetic enzymes such as EP300 and HDAC1, and non-coding RNAs such as XIST and HOTAIR.
How is gene expression regulated at the chromatin level?
Histone modifications, including acetylation and acylation, alter chromatin structure and recruit regulatory proteins to control transcription.
What is the role of long non-coding RNAs in gene regulation?
Cis-acting long non-coding RNAs can modulate transcription of neighboring genes by recruiting regulatory complexes.
How does post-transcriptional regulation affect gene expression?
It controls RNA processing, stability, and translation, thereby determining the amount of protein produced.
Why is regulation of gene expression important in cancer?
Dysregulated gene expression drives uncontrolled proliferation and survival, making it a central feature of cancer.
What methods are used to study regulation of gene expression?
Common methods include RNA-seq, Ribo-seq, ChIP-seq, proteomics, and CRISPR screens.
How can CRISPR be used to study gene expression regulation?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of regulatory genes and elements.
What diseases are linked to defects in gene expression regulation?
Cancer, leukemia, and various post-transcriptional diseases are linked to defects in this process.
How does metabolism influence gene expression?
Metabolic intermediates can modify histones and thereby regulate gene expression.
Conclusion
GO:0010468 regulation of gene expression is a central biological process that integrates chromatin, transcription, RNA processing, translation, and signaling to control the fate and function of cells. Its dysregulation is a common theme in cancer, leukemia, and other diseases, making it a key area for both basic and translational research. Advances in CRISPR-based models and high-throughput methods now allow researchers to dissect the causal roles of individual regulators and to identify new therapeutic targets within this process.
References
- 1. Sabari BR et al.. 2017. Metabolic regulation of gene expression through histone acylations.. Nat Rev Mol Cell Biol 18(2):90-101 PMID: 27924077
- 2. Koo H et al.. 2020. Regulation of gene expression by protein lysine acetylation in Salmonella.. J Microbiol 58(12):979-987 PMID: 33201432
- 3. Gil N et al.. 2020. Regulation of gene expression by cis-acting long non-coding RNAs.. Nat Rev Genet 21(2):102-117 PMID: 31729473
- 4. Ferlier T et al.. 2022. Regulation of Gene Expression in Cancer-An Overview.. Cells 11(24) PMID: 36552821
- 5. Gowda C et al.. 2020. Cellular signaling and epigenetic regulation of gene expression in leukemia.. Adv Biol Regul 75:100665 PMID: 31623972
- 6. Huang D et al.. 2021. Synthetic biology approaches in regulation of targeted gene expression.. Curr Opin Plant Biol 63:102036 PMID: 33930839
- 7. Mocchetti I. 2011. Pharmacological regulation of gene expression.. Pharmacol Res 64(4):323-6 PMID: 21708254
- 8. Corbett AH. 2018. Post-transcriptional regulation of gene expression and human disease.. Curr Opin Cell Biol 52:96-104 PMID: 29518673
